Key result
MRI-guided balloon angioplasty achieves procedural success and relieves coarctation gradients in ~80% of patients.
Why the study?
MRI guidance of percutaneous transluminal balloon angioplasty of aortic coarctation is desirable for continuous visualization and to eliminate x-ray exposure.
Does MRI-guided percutaneous transluminal balloon angioplasty using ferucarbotran allow for successful and accurate treatment of aortic coarctation compared to conventional catheterization?
Does MRI-guided percutaneous transluminal balloon angioplasty using ferucarbotran allow for successful and accurate treatment of aortic coarctation compared to conventional catheterization?
MRI-guided balloon angioplasty using ferucarbotran-treated catheters is feasible and represents a potential radiation-free alternative to conventional x-ray fluoroscopy for treating aortic coarctation.
Answers are grounded in this paper and cite their sources.
MRI-guided PTA with Resovist appears feasible in CoA; leaves open larger trials before clinical adoption.
BACKGROUND: MRI guidance of percutaneous transluminal balloon angioplasty (PTA) of aortic coarctation (CoA) would be desirable for continuous visualization of anatomy and to eliminate x-ray exposure. The aim of this study was (1) to determine the suitability of MRI-controlled PTA using the iron oxide-based contrast medium Resovist (ferucarbotran) for catheter visualization and (2) to subsequently apply this technique in a pilot study with patients with CoA. METHODS AND RESULTS: The MRI contrast-to-noise ratio and artifact behavior of Resovist-treated balloon catheters was optimized in in vitro and animal experiments (pigs). In 5 patients, anatomy of the CoA was evaluated before and after intervention with high-resolution respiratory-navigated 3D MRI and multiphase cine MRI. Position monitoring of Resovist-treated catheters was realized with interactive real-time MRI. Aortic pressures were continuously recorded. Conventional catheterization was performed before and after MRI to confirm interventional success. During MRI, catheters filled with 25 micromol of iron particles per milliliter of Resovist produced good signal contrast between catheters and their background anatomy but no image distortion due to susceptibility artifacts. All MRI procedures were performed successfully in the patient study. There was excellent agreement between the diameters of CoA and pressure gradients as measured during MRI and conventional catheterization. In 4 patients, PTA resulted in substantial widening of the CoA and a decrease in pressure gradients. In 1 patient, PTA was ineffective. CONCLUSIONS: The MRI method described represents a potential alternative to conventional x-ray fluoroscopy for catheter-based treatment of patients with CoA.
No takes yet. Share an insight, caveat, or question.
Krueger et al. (2006) studied Aortic coarctation (CoA) (n=5). MRI-guided percutaneous transluminal balloon angioplasty (PTA) using Resovist contrast was evaluated on Feasibility and procedural success (substantial widening of the CoA and a decrease in pressure gradients). MRI-guided balloon angioplasty was successfully performed, resulting in substantial widening of the coarctation and decreased pressure gradients in 4 out of 5 patients (80%).
Synapse has enriched 10 related papers. Consider them for comparative context: